Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Abatacept, rituximab or tocilizumab
(Rituxan, RITUXAN)		1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 46 💬
2ABP 798 biosimilar TO rituximab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
3Addition OF rituximab IF recurrence
(Rituxan, RITUXAN)		----1件: 11 💬
4Administration OF rituximab and methylprednisolone
(Rituxan, RITUXAN)		----1件: 51 💬
5Alemtuzumab and rituximab
(Rituxan, RITUXAN)		1件: Alemtuzumab1件: Alemtuzumab 💬 --1件: 60 💬
6Alemtuzumab, rituximab
(Rituxan, RITUXAN)		1件: Alemtuzumab1件: Alemtuzumab 💬 --1件: 63 💬
7Belimumab IN SLE patients / rituximab IN RA patients
(Rituxan, RITUXAN)		1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
8Bendamustine, rituximab
(Rituxan, RITUXAN)		1件: Bendamustine3件: Bendamustine hydrochloride ,
Bendamustine ,
Bendamustine hydrochloride hydrate 💬 		--1件: 61 💬
9Combination OF protein A immunoadsorption, rituximab, dexamethasone plus azathioprine
(Rituxan, RITUXAN)		----1件: 35 💬
10Combination OF rituximab with subcutaneous belimumab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
11Combined plasma exchange (PEX), rituximab, and corticosteroids
(Rituxan, RITUXAN)		----1件: 85 💬
12Cyclophosphamide/rituximab
(Rituxan, RITUXAN)		1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 13 💬
13Dexamethasone and rituximab
(Rituxan, RITUXAN)		1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
14Double-blind rituximab
(Rituxan, RITUXAN)		----1件: 51 💬
15DR. reddy’S rituximab (drl_ri) 100MG
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
16DR. reddy’S rituximab (drl_ri) 500MG
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
17Eltrombopag combining rituximab
(Rituxan, RITUXAN)		1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: TPOR 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
18Etanercepet, rituximab, abatacept, tocilizumab, sarilumab
(Rituxan, RITUXAN)		4件: Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		4件: Tocilizumab ,
Rituximab (Rituxan, RITUXAN),
Abatacept ,
Sarilumab 💬 		4件: CD80,
CD86,
IL6R,
MS4A1 💬 		24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46 💬
19GP2013 - A proposed biosimilar rituximab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
20Higher dose OF rituximab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
21Individualized dose OF rituximab
(Rituxan, RITUXAN)		----1件: 49 💬
22Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
(Rituxan, RITUXAN)		----1件: 13 💬
23Intravenous rituximab
(Rituxan, RITUXAN)		----1件: 66 💬
24Mabthera or biosimilar rituximab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 61 💬
25Mabthera or biosimilar rituximab product
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
26Mabthera/rituxan1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
27Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq
(Rituxan, RITUXAN)		1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
28Perfusion OF treatment rituximab
(Rituxan, RITUXAN)		----1件: 13 💬
29Prednisone, LOW dose rituximab
(Rituxan, RITUXAN)		1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 61 💬
30Rhtpo IN combination with rituximab
(Rituxan, RITUXAN)		1件: Recombinant Human Thrombopoietin---1件: 63 💬
31Rituxan1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬7件: 35, 46, 60, 61, 63, 256, 288 💬
32Rituxan (INN: rituximab), brand name IN THE united states1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
33Rituxan (INN: rituximab), brand name IN THE US1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
34Rituxan, cyclophosphamide, vincristine, prednisone1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
35Rituximab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
36Rituximab - mabthera
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
37Rituximab 1G IV
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
38Rituximab 1G/6months
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
39Rituximab 200MG/6months
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
40Rituximab and cyclophosphamide IV
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 35 💬
41Rituximab and dexamethasone
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
42Rituximab and hyaluronidase human
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 331 💬
43Rituximab combined with corticosteroids
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
44Rituximab combined with omalizumab
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 162 💬
45Rituximab combined with tacrolimus induction + rituximab maintenance
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
46Rituximab combined with tacrolimus induction + tacrolimus maintenance
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
47Rituximab infusion
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 13, 222 💬
48Rituximab injection
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 35, 222 💬
49Rituximab IT
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
50Rituximab IV
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
51Rituximab konsentrat TIL infusjonsvaeske oppløsning 10 MG/ML
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
52Rituximab mabthera
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
53Rituximab, cyclophosphamide, and corticosteroids
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
54Rituximab, mabthera
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 53 💬
55Rituximab, MTX, folic acid
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
56Rituximab, observational study amon patients with active RA
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
57Rituximab-EU+ rituximab-pfizer X 2 courses
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
58Rituximab-pfizer
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
59Rituximab-pfizer (PF-05280586) X 3 courses
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
60Rituximab-US + rituximab-pfizer X 2 courses
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
61Rituximab/ mabthera
(Rituxan, RITUXAN)		1件: Rituximab1件: Rituximab (Rituxan, RITUXAN) 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 271 💬
62Standard dose OF rituximab
(Rituxan, RITUXAN)		----1件: 49 💬
63THE standard steroid treatment, plasma exchange and rituximab
(Rituxan, RITUXAN)		----1件: 85 💬